Biomerica (BMRA) Net Cash Flow Growth (1y) (2011 - 2026)
Biomerica (BMRA) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 157.80 Bn | 151.14 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 115.54 Bn | 112.66 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 103.44 Bn | 95.27 Bn | 5.76 Bn | -562.50% |
| 4 | Boston Scientific | 72.38 Bn | 71.17 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 49.76 Bn | 46.09 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 29.53 Bn | 28.42 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 29.51 Bn | 27.44 Bn | 1.98 Bn | -394.13% |
| 8 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 76.43% |
| 9 | Steris | 20.69 Bn | 20.27 Bn | 697.10 Mn | 57.36% |
| 10 | Biomerica | 6.20 Mn | 4.87 Mn | -44,000.00 | -273.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -273.07% |
| Nov 30, 2025 | 35.65% |
| Aug 31, 2025 | 148.51% |
| May 31, 2025 | 37.64% |
| Feb 28, 2025 | 137.81% |
| Nov 30, 2024 | 7.38% |
| Aug 31, 2024 | 22.63% |
| May 31, 2024 | -116.76% |
| Feb 29, 2024 | -6.51% |
| Nov 30, 2023 | 14.60% |
| Aug 31, 2023 | -1,115.79% |
| May 31, 2023 | 250.22% |
| Feb 28, 2023 | -157.30% |
| Nov 30, 2022 | 50.39% |
| Aug 31, 2022 | -78.70% |
| May 31, 2022 | -295.07% |
| Feb 28, 2022 | 833.68% |
| Nov 30, 2021 | -57.61% |
| Aug 31, 2021 | 147.94% |
| May 31, 2021 | -117.19% |